Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Charles John O'donnell is active.

Publication


Featured researches published by Charles John O'donnell.


MedChemComm | 2012

A matched molecular pair analysis of in vitro human microsomal metabolic stability measurements for heterocyclic replacements of di-substituted benzene containing compounds – identification of those isosteres more likely to have beneficial effects

Alexander G. Dossetter; Adam Douglas; Charles John O'donnell

A matched molecular pair analysis (MMPA) was used to study the classic medicinal chemistry transformation of a di-substituted benzene into a heterocyclic ring. Matched pairs were identified for 45 heterocyclic transforms (5 and 6 membered rings) and in vitro human microsomal stability analysed. Of these, 12 transforms showed significant beneficial increase in stability, suggesting these heterocycles as preferred changes during compound optimisation.


MedChemComm | 2013

Optimisation of biphenyl acetic acid inhibitors of diacylglycerol acetyl transferase 1 – the discovery of AZD2353

Michael J. Waring; Alan Martin Birch; Susan Birtles; Linda K. Buckett; Roger John Butlin; Leonie Campbell; Pablo Morentin Gutierrez; Paul D. Kemmitt; Andrew G. Leach; Philip A. MacFaul; Charles John O'donnell; Andrew V. Turnbull

Inhibition of diacylglycerol acetyl transferase 1 is of great interest in the treatment of diabetes, obesity and other diseases that constitute the metabolic syndrome. Small molecule inhibitors of the enzyme are often dogged with physicochemical property-related problems such as poor solubility. Herein, the optimisation of a series of biphenyl acetic acid inhibitors is reported. Focus on ligand efficiency and ligand lipophilicity efficiency and a strategy based on conformational restriction led to compounds with excellent potency and ADMET properties, culminating in the discovery of AZD2353.


Archive | 2007

Sulfonamide derivatives for therapeutic use as fatty acid synthase inhibitors

Roger John Butlin; Peter William Rodney Caulkett; Petra Johannesson; Laurent Knerr; Andrew G. Leach; Nicholas John Newcombe; Charles John O'donnell; Helen Pointon


Archive | 2007

Piperidine derivatives for the treatment of obesity

Roger John Butlin; Peter William Rodney Caulkett; Andrew G. Leach; Nicholas John Newcombe; Charles John O'donnell


Archive | 2007

Therapeutic Agents - 551

Roger John Butlin; Peter William Rodney Caulkett; Andrew G. Leach; Nicholas John Newcombe; Charles John O'donnell


Archive | 2007

Therapeutic Agents - 550

Roger John Butlin; Peter William Rodney Caulkett; Petra Johannesson; Laurent Knerr; Andrew G. Leach; Nicholas John Newcombe; Charles John O'donnell; Helen Pointon


Archive | 2010

Therapeutic Agents 812

Alan Martin Birch; Roger John Butlin; David S. Clarke; Andrew G. Leach; Philip A. MacFaul; Charles John O'donnell; James S. Scott; Paul Robert Owen Whittamore; Dan Anders Broo; Öjvind Davidsson; Kjell Erik Johansson; Hanna De La Motte


Archive | 2010

4- (pyrimidin-2-yl) -piperazine and 4- (pyrimidin-2-yl) -piperidine derivatives as gpr119 modulators

Alan Martin Birch; Dan Anders Broo; Roger John Butlin; David S. Clarke; Öjvind Davidsson; La Motte Hanna De; Kjell Erik Johansson; Andrew G. Leach; Philip A. MacFaul; Charles John O'donnell; James S. Scott; Paul Robert Owen Whittamore


Archive | 2010

Derives de 4-(pyrimidin-2-yl)-piperazine et de 4-(pyrimidin-2-yl)-piperidine utilises en tant que modulateurs du gpr119

Alan Martin Birch; Dan Anders Broo; Roger John Butlin; David S. Clarke; Öjvind Davidsson; La Motte Hanna De; Kjell Erik Johansson; Andrew G. Leach; Philip A. MacFaul; Charles John O'donnell; James S. Scott; Paul Robert Owen Whittamore


Archive | 2007

Dérivés de sulfonamide à usage thérapeutique en tant qu'inhibiteurs de synthase d'acides gras

Roger John Butlin; Peter William Rodney Caulkett; Petra Johannesson; Laurent Knerr; Andrew G. Leach; Nicholas John Newcombe; Charles John O'donnell; Helen Pointon

Collaboration


Dive into the Charles John O'donnell's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Andrew G. Leach

Liverpool John Moores University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge